A new PARP inhibitor for treating ovarian cancer: senaparib

Yuan WANG, Xiaoyu WANG, Huibo LI

Clinical Medication Journal ›› 2026, Vol. 24 ›› Issue (10) : 13-17.

PDF(577 KB)
Welcome to visit Clinical Medication Journal!
PDF(577 KB)
Clinical Medication Journal ›› 2026, Vol. 24 ›› Issue (10) : 13-17. DOI: 10.3969/j.issn.1672-3384.2026.10.003
Comment of New Drug

A new PARP inhibitor for treating ovarian cancer: senaparib

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 24(10): 13-17 https://doi.org/10.3969/j.issn.1672-3384.2026.10.003

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(577 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉